These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21205251)

  • 21. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
    Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
    Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anticoagulation in patients with atrial fibrillation].
    Mügge A
    Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental?
    Setiabudi E; Alwi I; Setiati S
    Acta Med Indones; 2008 Jan; 40(1):40-7. PubMed ID: 18326899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
    Morgan SV
    Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
    [No Abstract]   [Full Text] [Related]  

  • 25. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral anticoagulation and stroke in atrial fibrillation.
    Boos CJ
    N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674043
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 30. Atrial fibrillation, thromboembolism and antithrombotic therapy.
    Li-Saw-Hee FL; Lip GY
    Int J Clin Pract; 1999 Mar; 53(2):110-7. PubMed ID: 10344046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
    Middlekauff HR; Stevenson WG; Gornbein JA
    Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 33. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
    Thibault B; Talajic M; Dubuc M; Guerra P; Gagné P; Roy D; Connolly S;
    Can J Cardiol; 2004 Feb; 20(2):195-9. PubMed ID: 15010743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
    King DE; Dickerson LM; Sack JL
    Am Fam Physician; 2002 Jul; 66(2):261-4. PubMed ID: 12152961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
    Schulman S
    N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
    [No Abstract]   [Full Text] [Related]  

  • 37. Atrial fibrillation--rate versus rhythm control.
    Manning WJ
    N Engl J Med; 2003 Mar; 348(13):1284-6; author reply 1284-6. PubMed ID: 12661569
    [No Abstract]   [Full Text] [Related]  

  • 38. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

  • 39. Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation.
    Hylek EM; Magnani JW
    Europace; 2008 Jan; 10(1):3-5. PubMed ID: 18039690
    [No Abstract]   [Full Text] [Related]  

  • 40. Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies.
    Smith MB; Christensen N; Wang S; Strohecker J; Day JD; Weiss JP; Crandall BG; Osborn JS; Anderson JL; Horne BD; Muhlestein JB; Lappe DL; Moss H; Oliver J; Viau K; Bunch TJ
    Cardiology; 2010; 116(1):61-9. PubMed ID: 20502012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.